Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. - Wikidata - awgldk - TriplyDB

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

http://www.wikidata.org/entity/Q42704864

about

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance.Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase Probiotics and prebiotics in chronic inflammatory bowel diseases.Probiotics-host communication: Modulation of signaling pathways in the intestine.A Lactobacillus rhamnosus strain induces a heme oxygenase dependent increase in Foxp3+ regulatory T cells.Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.Gut ecosystem: how microbes help us.Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health.Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.Host-Microbiome Cross-talk in Oral Mucositis Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells.Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.Evolving knowledge and therapy of inflammatory bowel disease.Biofilm-associated bacterial amyloids dampen inflammation in the gut: oral treatment with curli fibres reduces the severity of hapten-induced colitis in mice Probiotics: properties, examples, and specific applications.Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.Probiotics and small bowel mucosa: Molecular aspects of their interactions.A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.Rationale for probiotic treatment strategies in inflammatory bowel disease.Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease.Use of probiotics in gastrointestinal disorders: what to recommend?Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.Non-dairy probiotic beverages: the next step into human health.Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in e Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells.Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

P2860

Q26746916-DECEF067-6E06-4BDF-89AF-5A511689239E Q26825483-2F862C5F-3BE7-4984-AD74-B8F4A242A64F Q27304899-069798A8-281C-456F-B6BD-BCFB7EE3A675 Q33847243-4EDF04C5-052E-46C0-BFC5-44DD926BAE1F Q34013030-25B2C3D7-1A99-4F52-9380-5F32E7931F62 Q34018028-1DCC7CDC-06AF-478F-85A1-F30DCDD60976 Q34450919-31964608-260B-417B-8E78-8D3017ACB154 Q34576021-60E96CF1-0E76-4E6D-94F1-9B0DF78B8087 Q34579758-CA270C91-1A82-4A76-8BD7-93CC5669AA2E Q34588415-FB0D6F8E-BEF3-413F-AF44-7653F81E08B3 Q34744012-BAA8C84A-67DD-47D7-8ED9-5FEFD5B88296 Q35105266-DEB2D405-9CE3-4B01-AF52-AEEA087F100C Q35581546-5398C538-3CBE-4906-B5AB-CAEC6721936D Q35901914-79C3C468-0E9E-4D38-A8B8-BDFEBE9FC38E Q35981844-7758F4C9-8EE1-4EB1-8466-AF1D082FB2AE Q36166571-D99264DC-FFF7-4871-AF91-3FC2F679C4B7 Q36361827-C92AF633-8B97-4622-AFA7-3AC2F406FAF7 Q36414506-051D7399-FB35-4801-8AE5-5B495FE8C9E7 Q36539870-721869B7-C99B-46C3-8195-7C9D6E0067BF Q36629073-F484477D-6F92-4B9D-8ED2-86B1E613A11B Q36890709-9E9F1B6E-0DB4-48F1-BFBD-9EF6E8405FEA Q37214848-436F3279-9281-4389-8FC6-0FCFA3386028 Q37292430-ED9A5289-A795-4235-8039-E3C040096B5E Q37332655-AB9D4591-BED5-468D-9CF5-56265820E580 Q37345932-82A746A2-B53A-48C7-8D64-7E3010FA1F97 Q37729039-F615D65D-433E-4CE9-B6A3-75270799424F Q37823328-60D0AC95-26AE-4D37-9E79-EEDAE214F81E Q37969596-A7BAF7EB-3548-4CE8-9282-11F622156CB2 Q38070060-7E46A789-C64E-40D1-ACD3-DF84A3C9321B Q38122352-F08DE129-18CB-448F-920D-DB0578D01BA8 Q38548793-DAEB1F27-720E-4DB2-9F5C-ACF420D8C9EB Q39741559-4E71588F-2CA9-46BB-BF7F-43B91AA49108 Q39879434-05F60408-AFB5-4C2D-A017-C7EAB2BD4BF8 Q40060675-5DA201B8-B710-491B-BD16-CE97E23273C2 Q40264330-D660B1B8-4482-40EC-AB98-071E5028F817 Q40569121-193CBE4F-7850-4D8F-875A-8EDFFF9A227E Q40600252-D3EA68AB-1088-4AE0-BA81-9F9718D47C49 Q40974571-001A2026-E3B5-457E-988D-023B125B1B8A Q41673047-CBB5238B-0BF7-49C9-B2AD-D8ECCF9AA530 Q41761349-717D7AFB-52C4-497A-A78F-BBB44E24B1D7

P2860

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

http://www.wikidata.org/entity/Q42704864

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@en

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@nl

type

label

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@en

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@nl

prefLabel

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@en

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@nl

P1433

Q42704864-8E142BCA-0CF5-4D0B-AA8D-2EE665C3D7F8

P1476

Q42704864-B26C97EB-5620-4613-8F80-A65ABC7BC908

P2093

Q42704864-293DC2F6-55A2-48D5-8922-3B2BC64C31A9

Q42704864-47A15CF6-D84A-407A-88A0-E91CC6FF453F

Q42704864-4C6F38A4-D3AB-4526-8F88-711532717241

Q42704864-64879862-C02B-4BC9-94BF-6E14A1CF945B

Q42704864-6A236E1B-1A7F-4844-92AD-B4C79049FE7E

Q42704864-704508D4-2D8C-49B8-9B28-0BCC4FA33BB5

Q42704864-865CEBB0-08A1-4508-899A-B0FA866D34B3

Q42704864-8829C2DF-1D0E-4413-BCA4-B7C6FECAF981

Q42704864-915812C7-009C-408D-AC50-4A53EE4C8519

Q42704864-AB4B8B85-00BF-4244-8284-3183D1707482

P2860

Q42704864-02CFE597-1BF0-4F36-93DA-6397D480C8FD

Q42704864-03006F17-3FBD-4143-A6B9-F283D67E634F

Q42704864-04CA18D9-BEC8-4F96-99E6-7DE7E160F126

Q42704864-05480902-3427-4A0F-88BB-B45B0F87D6DD

Q42704864-05F52AE9-BD1A-4617-B18D-45CE02A916E2

Q42704864-07D891E5-17B5-424B-BED5-97B45C1B1195

Q42704864-0C768D86-35F2-454E-A4B5-1A97896B11EB

Q42704864-0E05FDDC-8F10-4E41-BFA9-7C18DC711416

Q42704864-0E8D2DFC-F6AE-4AA3-989D-2AEF60E51F73

Q42704864-126DDBDF-CB56-4E71-BACB-0C26403E130F

P304

Q42704864-83047932-CB6F-4B67-9D00-1F547AC580A4

P31

Q42704864-F0225494-1994-4942-B453-81ABA5610DC1

P356

Q42704864-1CF07DC5-E816-4FB6-98F7-C46E7C603380

P407

Q42704864-CAAEA98A-B5CF-4293-9B8B-C8A83D25261D

P433

Q42704864-75E16328-C34A-40E8-B01C-E63930BA5DFB

P478

Q42704864-91715DD6-7F08-4299-95A8-2C3920AEEEEC

P577

Q42704864-6308ADFC-31DE-40FC-9DB3-FB34FEAFEB09

P5875

Q42704864-D59F389E-D8DB-4BFB-8E2F-48F58A06D19D

P698

Q42704864-621A77CF-18B8-4106-80BC-C0E0E2630435

P921

Q42704864-784F5FDD-7FCE-40F0-B7E4-41B48D8227FF

P932

Q42704864-E28B820B-6EA5-4D58-810C-C645066832E4

P356

IAI.73.3.1452-1465.2005

P1433

Infection and Immunity

P1476

Escherichia coli Nissle 1917 d ...... oll-like receptor 2 signaling.

@en

P2093

Andreas Sturm

http://www.w3.org/2001/XMLSchema#string

Axel U Dignass

http://www.w3.org/2001/XMLSchema#string

Bertram Wiedenmann

http://www.w3.org/2001/XMLSchema#string

Bärbel Raupach

http://www.w3.org/2001/XMLSchema#string

Corinne Enders

http://www.w3.org/2001/XMLSchema#string

Daniel C Baumgart

http://www.w3.org/2001/XMLSchema#string

Jana Eckert

http://www.w3.org/2001/XMLSchema#string

Klaus Rilling

http://www.w3.org/2001/XMLSchema#string

Konstantinos Gargas

http://www.w3.org/2001/XMLSchema#string

Ralf R Schumann

http://www.w3.org/2001/XMLSchema#string

P2860

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

Structure of a human gammadelta T-cell antigen receptor

The retinoblastoma protein and cell cycle control

CDK inhibitors: positive and negative regulators of G1-phase progression

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Microbial isoprenoid biosynthesis and human gammadelta T cell activation

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

G1 phase progression: cycling on cue

Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.

P304

1452-1465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.73.3.1452-1465.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8002682

http://www.w3.org/2001/XMLSchema#string

P698

15731043

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1064918

http://www.w3.org/2001/XMLSchema#string